Completed PHASE1 INTERVENTIONAL NCT00460785

Bioequivalence Trial of a New Opioid Combination Compared to Reference

Phase 1 Single Center Trial to Demonstrate the Bioequivalence of a New Combination Analgesic Formulation as Compared to an Equimolar Marketed Formulation

Sponsor: Grünenthal GmbH

Conditions Healthy

Interventions Opioid

Updated 5 times since 2017 Last updated: Jul 5, 2007 Started: Feb 28, 2007 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently completed. Grünenthal GmbH leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Grünenthal GmbH

Data source: Grünenthal GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.